OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
April 09, 2021
A picture of wide manufacturing violations appears in a recently disclosed FDA form 483 report on a site visit to Emergent’s Baltimore vaccine plant.
April 06, 2021
André Sode, CEO of Liva Healthcare, talks about Liva’s collaboration with Amgen to co-create an innovative digital tele-rehabilitation solution called Rehab+.
April 01, 2021
Next tier of markets is poised to ascend and offer valuable opportunities to both investors and occupiers.
March 31, 2021
Healthcare providers across Canada will be able to capture adverse events in the Auxita platform through integration with MyMeds&Me’s pharmacovigilance SaaS platform, Reportum.
This month brings the IR35 tax reform on the UK’s private sector. How will it affect the pharma industry?
March 30, 2021
New product expands outreach of medical affairs organizations.
March 24, 2021
A coalition of biopharma and technology leaders have announced a new strategic collaboration to promote new and updated standards for advanced therapies.
Research shows ESG performance is strongly predictive of long-term value creation and financial performance, when a sector-specific approach is maintained.
March 18, 2021
Report provides comprehensive look at financial and accounting issues faced by life sciences industry.
March 17, 2021
Federal Trade Commission to launch a broad review of drug-company mergers.